These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28558028)

  • 41. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Geometry-independent assessment of renal volume in polycystic kidney disease from magnetic resonance imaging.
    Turco D; Severi S; Mignani R; Magistroni R; Corsi C
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():3081-4. PubMed ID: 26736943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study.
    Woznicki P; Siedek F; van Gastel MDA; Dos Santos DP; Arjune S; Karner LA; Meyer F; Caldeira LL; Persigehl T; Gansevoort RT; Grundmann F; Baessler B; Müller RU
    Kidney360; 2022 Dec; 3(12):2048-2058. PubMed ID: 36591351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview.
    Corradi V; Gastaldon F; Virzì GM; Caprara C; Martino F; Ronco C
    Minerva Med; 2015 Feb; 106(1):53-64. PubMed ID: 25300895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of kidney volume in polycystic kidney disease using magnetic resonance imaging without contrast medium.
    Mignani R; Corsi C; De Marco M; Caiani EG; Santucci G; Cavagna E; Severi S; Cagnoli L
    Am J Nephrol; 2011; 33(2):176-84. PubMed ID: 21311183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
    Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
    Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cisterna chyli in autosomal dominant polycystic kidney disease.
    Thimmappa ND; Blumenfeld JD; Cerilles MA; Dunning A; Donahue SL; Bobb WO; Zhang HL; Prince MR
    J Magn Reson Imaging; 2015 Jan; 41(1):142-8. PubMed ID: 24470398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Semiautomated Segmentation of Polycystic Kidneys in T2-Weighted MR Images.
    Kline TL; Edwards ME; Korfiatis P; Akkus Z; Torres VE; Erickson BJ
    AJR Am J Roentgenol; 2016 Sep; 207(3):605-13. PubMed ID: 27341140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fully Automated Segmentation of Polycystic Kidneys From Noncontrast Computed Tomography: A Feasibility Study and Preliminary Results.
    Turco D; Valinoti M; Martin EM; Tagliaferri C; Scolari F; Corsi C
    Acad Radiol; 2018 Jul; 25(7):850-855. PubMed ID: 29331360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Kim Y; Ge Y; Tao C; Zhu J; Chapman AB; Torres VE; Yu AS; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT;
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):576-84. PubMed ID: 26797708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease.
    Breysem L; De Rechter S; De Keyzer F; Smet MH; Bammens B; Van Dyck M; Hofmans M; Oyen R; Levtchenko E; Mekahli D
    Pediatr Nephrol; 2018 May; 33(5):827-835. PubMed ID: 29306987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A; Lu Y; Kawano H; Horie S; Muto S
    Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging.
    Akbari P; Nasri F; Deng SX; Khowaja S; Lee SH; Warnica W; Lu H; Rattansingh A; Atri M; Khalili K; York P
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):827-834. PubMed ID: 35383043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease.
    Yoshida H; Higashihara E; Maruyama K; Nutahara K; Nitatori T; Miyazaki I; Shiokawa Y
    Acta Neurochir (Wien); 2017 Dec; 159(12):2325-2330. PubMed ID: 28884237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography - high speed and accuracy.
    Aapkes SE; Barten TRM; Coudyzer W; Drenth JPH; Geijselaers IMA; Ter Grote SAM; Gansevoort RT; Nevens F; van Gastel MDA
    Eur Radiol; 2023 May; 33(5):3222-3231. PubMed ID: 36640173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
    Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
    J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and Evaluation of a Semi-automated Segmentation Tool and a Modified Ellipsoid Formula for Volumetric Analysis of the Kidney in Non-contrast T2-Weighted MR Images.
    Seuss H; Janka R; Prümmer M; Cavallaro A; Hammon R; Theis R; Sandmair M; Amann K; Bäuerle T; Uder M; Hammon M
    J Digit Imaging; 2017 Apr; 30(2):244-254. PubMed ID: 28025731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.
    D'Agnolo HMA; Casteleijn NF; Gevers TJG; de Fijter H; van Gastel MDA; Messchendorp AL; Peters DJM; Salih M; Soonawala D; Spithoven EM; Visser FW; Wetzels JFM; Zietse R; Gansevoort RT; Drenth JPH
    Am J Nephrol; 2017; 46(3):239-248. PubMed ID: 28881341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
    BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
    Perrone RD; Neville J; Chapman AB; Gitomer BY; Miskulin DC; Torres VE; Czerwiec FS; Dennis E; Kisler B; Kopko S; Krasa HB; LeRoy E; Castedo J; Schrier RW; Broadbent S
    Am J Kidney Dis; 2015 Oct; 66(4):583-90. PubMed ID: 26088508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.